FIELD: chemistry.
SUBSTANCE: invention relates to microbiology and genetic engineering and discloses a recombinant plasmid DNA pMind-vapB, which is plasmid pMind into which a sequence shown on fig 2 is cloned.
EFFECT: recombinant plasmid DNA pMind-vapB enables hyper-expression of the VapB antitoxin in Mycobacterium tuberculosis strains.
6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT PLASMID DNA pMind-vapC, CONTAINING vapC MSMEG_1284 GENE CODING NUCLEOTIDE SEQUENCE | 2012 |
|
RU2524143C2 |
| DNA FRAGMENT COMPRISING NUCLEOTIDE SEQUENCE WITH INVERTED MITEKPNL REPEATS IN COLISTIN-RESISTANT STRAINS OF KLEBSIELLA PNEUMONIAE | 2020 |
|
RU2736114C1 |
| TEST SYSTEM OF Mycobacterium smegmatis aphVIII + FOR SCREENING OF INHIBITORS OF SERINE-THREONINE PROTEIN KINASES OF EUKARYOTIC TYPE | 2014 |
|
RU2566998C1 |
| METHOD FOR MODELING THE DORMANT STATE OF MYCOBACTERIUM TUBERCULOSIS IN VITRO | 2018 |
|
RU2707941C1 |
| METHOD OF PREPARATION OF RECOMBINANT BIRDS VIRUS FOR VACCINATION AND GENETIC THERAPY | 2007 |
|
RU2326942C1 |
| NEW EFFECTIVE THERAPEUTIC TARGET FOR TREATING TUBERCULOSIS | 2008 |
|
RU2474621C2 |
| METHOD OF PRODUCING EXPRESSION PLASMID VECTOR SHOWING HIGHER INHERITANCE STABILITY IN Escherihia coli CELLS | 2008 |
|
RU2422504C2 |
| ALLERGEN CONTAINING COMBINATION OF PROTEIN SEQUENCES ENCODED BY M.TUBERCULOSIS COMPLEX EsxA, EsxB, EspJ, EspK GENES, AND METHOD FOR ITS APPLICATION FOR DIAGNOSIS OF MTUBERCULOSIS COMPLEX INFECTION | 2017 |
|
RU2636490C1 |
| VACCINES OF RECOMBINANT INTRACELLULAR PATHOGENS AND USES THEREOF | 2001 |
|
RU2266132C2 |
| RECOMBINANT PLASMID DNA pZIFN2α ENCODING SYNTHESIS OF HUMAN ALPHA-2b-INTERFERON AND STRAIN ESCHERICHIA COLI AS PRODUCER OF HUMAN ALPHA-2b-INTERFERON | 2002 |
|
RU2229517C1 |
